Table 1.
Patients characteristics.
| Group 1 (n = 71) | Group 2 (n = 40) | |
|---|---|---|
| Median age | 55 years [20–84] | 58 years [26–82] |
| Sex | 30 Male | 25 Male |
| 41 Female | 15 Female | |
| Department | ||
| Internal medecine | ||
| Inpatients | 5 | 1 |
| Outpatients | 18 | 1 |
| Cardiology | ||
| Inpatients | 26 | 28 |
| Outpatients | 22 | 10 |
| VKA indication | ||
| Secondary prevention of deep vein thrombosis | 20 | 1 |
| Secondary prevention of pulmonary embolism | 1 | 0 |
| Atrial fibrillation | 31 | 32 |
| Valvular cardiopathy | 10 | 0 |
| Valvular prothesis | 6 | 7 |
| Superficial thrombophlebitis | 1 | 0 |
| Intraventricular thrombus | 2 | 0 |
| Age of VKA therapy | ||
| [3 months–1 year] | 14 (20%) | 6 (16%) |
| [1 year–5 years] | 17 (24%) | 10 (23%) |
| ≤3 months | 11 (15%) | 4 (10%) |
| ≥5 years | 29 (41%) | 20 (51%) |